PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling

Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver disease in the world, however, no drug treatment has been approved for this disease. Thus, it is urgent to find effective therapeutic targets for clinical intervention. In this study, we find that liver-specific kn...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Commun
Main Authors: Ma, Ning, Wang, Yi-Kang, Xu, Sheng, Ni, Qian-Zhi, Zheng, Qian-Wen, Zhu, Bing, Cao, Hui-Jun, Jiang, Hao, Zhang, Feng-Kun, Yuan, Yan-Mei, Zhang, Er-Bin, Chen, Tian-Wei, Xia, Ji, Ding, Xu-Fen, Chen, Zhen-Hua, Zhang, Xiu-Ping, Wang, Kang, Cheng, Shu-Qun, Qiu, Lin, Li, Zhi-Gang, Yu, Yong-Chun, Wang, Xiao-Fan, Zhou, Bin, Li, Jing-Jing, Xie, Dong
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8144412/
https://ncbi.nlm.nih.gov/pubmed/34031390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-021-23285-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados